The Ministry of Health and Welfare said it would push for a revision of the medical law to mandate a certain proportion of intensive care units (ICUs) to be single-person rooms, instead of multi-person rooms.Korea has 9,190 ICUs at 167 medical institutions with more than 300 hospital beds, and 76 pe
LN Robotics said on Friday that it obtained approval from the Ministry of Food and Drug Safety (MFDS) for its All-purpose Vascular Intervention Assist Robot (AVIAR) in Korea.AVIAR is a vascular intervention robot with a focus on percutaneous coronary interventions to treat cardiovascular diseases re
The National Epilepsy Care Center rehomed Lily, Korea's first epilepsy helper dog, to an epilepsy patient.According to the center, while there were helper dogs for visual, hearing, and physical disabilities in Korea, the National Epilepsy Care Center was able to successfully train and rehome an epil
Celltrion said it has signed a joint research and development contract with LISCure Biosciences for a microbiome Parkinson's disease treatment candidate.Under the accord, the two companies will jointly develop oral Parkinson's disease microbiome-based live biotherapeutic products.Celltrion will prov
Lunit, a Korean biopharmaceutical company specializing in artificial intelligence (AI)-based cancer solutions, said on Friday that it will establish a new subsidiary in Amsterdam, the Netherlands, following a board of directors meeting held on Thursday.Accordingly, Lunit Inc. will hold a 100 percent
As one of the largest investors in research and development, Roche Diagnostics revealed plans to tackle tuberculosis (TB) which remains a pressing issue for the Asian region. The diagnostic giant also recently joined forces with the Korea Health Industry Development Institute (KHIDI) to cooperate on
A study has shown that diabetes treatment "pioglitazone" can lower the risk of dementia in diabetic patients.Researchers at Severance Hospital and National Cancer Center followed up on 91,218 people first diagnosed with diabetes based on National Health Insurance data for about 10 years. They found
GSK’s Shingrix, which many industry watchers expected would change the landscape of the Korean shingles vaccine market with the January launch, is actually facing a weaker-than-expected demand due to its high price, local dermatologists said.Shingrix prevents shingles in adults over 50 or people ove
BMS has successfully completed a confirmatory clinical trial of its chimeric antigen receptor T (CAR-T) cell therapy, Abecma (idecabtagene vircleucel; ide-cel), moving closer to formal approval from the U.S. Food and Drug Administration (FDA).However, steps have yet to be taken to authorize and rele
Handok, which reaffirmed its strong position in the diabetes area with sales of 100 billion won ($80 million) in this sector last year, has thrown a gauntlet to the anticancer treatment market.The company will also continue to secure competitive products to continue its growth pace, according to its
The healthcare industry is closely watching the results of the technical dispute mediation applied by Algocare against Lotte Healthcare.Algocare suspects that Lotte Healthcare had stolen its technology in developing Cazzle, the latter's nutrient dispenser.According to the Ministry of SMEs and Startu
Medtronic Korea said it has initiated a large-scale domestic recall of its natural bone graft products.The company recalled Grafton DBM (model name: T45001INT) due to concerns about damage to the sterilization package exterior during the product packaging process of natural bone graft. There are 11,
Kangstem Biotech said on Wednesday that it signed a memorandum of understanding with P&K Skin Clinical Research Center to conduct joint research for the development of a skin organoid-based drug efficacy evaluation platform.Under the accord, the two companies plan to develop a platform technology fo
Eutilex, a Korean biotech firm, said it would conduct a clinical trial to develope a home-grown chimeric antigen receptor T cell (CAR-T) therapy. The company said on Wednesday the Ministry of Food and Drug Safety approved its plan to test EU307, an investigational CAR-T therapy in hepatocellular car
KAIST said on Wednesday that its researchers identified mutations present in trace amounts of brain cells in patients with local cortical dysplasia, an intractable epilepsy in children, laying the foundation for developing a treatment.Epilepsy is a neurological disorder characterized by repeated sei
Cholera has seen a recent resurgence with outbreaks popping up one after the other prompted by climate change, wars, and natural disasters wreaking havoc on fragile health systems, as seen in Pakistan, Nigeria, and Malawi. Most recently, the earthquake in Syria and Turkey has added to the concerns a
Asan Medical Center (AMC) said on Wednesday that it began home medical care services for seriously ill pediatric patients aged under 18.To do so, the hospital formed a home medical care team consisting of pediatricians, coordinator nurses, and visiting nurses.When a pediatric patient is deemed to re
Daewoong Pharmaceutical said it has submitted a request for a suspension of execution to the Seoul Central District Court on Wednesday regarding the judgment in a civil lawsuit against Medytox related to the theft of botulinum strain (BTX) strain.Previously, the Seoul Central District Court ruled in
Parkinson’s disease inevitably accompanies long-term fights on the part of patients. Therefore, efforts are being made in and out of the medical community to raise patients’ survival rates and improve their quality of life.“Percept PC,” developed by Medtronic using deep brain stimulation (DBS), is a
Astellas Korea said it appointed Kim Jun-il, former vice president and head of strategy and operations at Bayer APAC, as its new General Manager (GM).t is the first time in about six years for Astellas Korea to have a Korean GM since the resignation of Jung Hae-do in 2017. Astellas' Korean offshoot